- Home
- FGMC vs COYA Comparison
FGMC vs COYA Comparison
Compare FGMC & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGMC
- COYA
- Stock Information
- Founded
- FGMC 2023
- COYA 2020
- Country
- FGMC United States
- COYA United States
- Employees
- FGMC N/A
- COYA N/A
- Industry
- FGMC
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- FGMC
- COYA Health Care
- Exchange
- FGMC NYSE
- COYA Nasdaq
- Market Cap
- FGMC 98.9M
- COYA 99.8M
- IPO Year
- FGMC 2025
- COYA 2022
- Fundamental
- Price
- FGMC $9.78
- COYA $5.53
- Analyst Decision
- FGMC
- COYA Strong Buy
- Analyst Count
- FGMC 0
- COYA 4
- Target Price
- FGMC N/A
- COYA $17.00
- AVG Volume (30 Days)
- FGMC 30.4K
- COYA 42.5K
- Earning Date
- FGMC 01-01-0001
- COYA 05-13-2025
- Dividend Yield
- FGMC N/A
- COYA N/A
- EPS Growth
- FGMC N/A
- COYA N/A
- EPS
- FGMC 0.08
- COYA N/A
- Revenue
- FGMC N/A
- COYA $3,685,107.00
- Revenue This Year
- FGMC N/A
- COYA $94.45
- Revenue Next Year
- FGMC N/A
- COYA N/A
- P/E Ratio
- FGMC $566.65
- COYA N/A
- Revenue Growth
- FGMC N/A
- COYA N/A
- 52 Week Low
- FGMC $9.53
- COYA $4.65
- 52 Week High
- FGMC $9.85
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- FGMC N/A
- COYA 41.95
- Support Level
- FGMC N/A
- COYA $5.27
- Resistance Level
- FGMC N/A
- COYA $5.99
- Average True Range (ATR)
- FGMC 0.00
- COYA 0.30
- MACD
- FGMC 0.00
- COYA -0.05
- Stochastic Oscillator
- FGMC 0.00
- COYA 18.14
About FGMC FG MERGER II CORP
FG Merger II Corp is a blank check company, incorporated for the purpose of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (Business Combination).
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.